In CFS/ME, disruptions in this axis are believed to play a central role in the manifestation of fatigue, cognitive dysfunction, and mood disturbances (Knig et al., 2021)
Fortunately, there are some simple steps you can take to reduce the amount of stomach acid and prevent this pressure build-up
Flexible Titration Baseline: Specially designed to allow a seamless transition from the initial 0.25mg activation dose (weeks 14) straight up to the 0.5mg optimization dose (weeks 5+) using the same stable platform
doi: 10.1111/1753-0407.12891 Summary Keywords diabetic kidney disease, diabetic nephropathy, GLP-1 receptor agonists, liraglutide, semaglutide, dulaglutide Citation Kawanami D and Takashi Y (2020) GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms
Trough measurements, taken the morning before the next injection, show the lowest point in the cycle